EP1212444A1 - Dna construct and its use - Google Patents
Dna construct and its useInfo
- Publication number
- EP1212444A1 EP1212444A1 EP00966616A EP00966616A EP1212444A1 EP 1212444 A1 EP1212444 A1 EP 1212444A1 EP 00966616 A EP00966616 A EP 00966616A EP 00966616 A EP00966616 A EP 00966616A EP 1212444 A1 EP1212444 A1 EP 1212444A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- oilseed plant
- xanthophyll
- dna construct
- peptide
- nucleotide sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0069—Oxidoreductases (1.) acting on single donors with incorporation of molecular oxygen, i.e. oxygenases (1.13)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
- C12N15/8247—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving modified lipid metabolism, e.g. seed oil composition
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
- C12N15/825—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving pigment biosynthesis
Definitions
- the present invention relates to a new DNA construct for transformation into oilseed plants.
- the DNA construct comprises nucleotide sequences encoding peptides with enzyme activities necessary for the high-level production and esterification of keto group-containing xanthophylls in oilseed plants.
- Carotenoids are produced de novo by plants, fungi, algae and some bacteria. A number of biosynthetic steps are needed for the biological production of the carotenoids. There are two chemically different groups of carotenoids, namely carotenes containing only carbon and hydrogen molecules and xanthophylls containing oxygen in the molecule in addition to carbon and hydrogen.
- the xanthophylls and particularly astaxanthin (3,3'-dihydroxy- ⁇ - ⁇ -carotene-4,4'- dione), are often colored pigments and are used as such or as anti-oxidants.
- Carotenes are biological precursors for the production of the oxygen-containing xanthophylls. There are two types of enzymes responsible for the introduction of hydroxy groups and keto groups into the carotenes, namely hydroxylases and ketolases, respectively.
- keto group-containing xanthophyll astaxanthin which has keto and hydroxy groups, is biosynthetically produced from beta-carotene.
- Large-scale production of xanthophylles from natural sources is at present performed by AstaCarotene AB, Gustavsberg, Sweden, by cultivation of the alga Haematococcus pluvialis for the production of astaxanthin in esterified form.
- Oilseed plants have naturally ⁇ -carotene hydroxylases but lack ⁇ -carotene C-4-oxygenase enzymes or ketolases.
- the present invention provides DNA constructs enabling and promoting production of keto group containing xanthophylls, especially astaxanthin, in oilseed plants, such as rape, sunflower, soybean and mustard.
- the DNA construct is transformed into the oilseed plant cell for expression of a protein or fused protein which has an enzyme activity enabling keto group insertion into a carotene or hydroxy carotene for the biosynthetic production of a keto group containing xanthophyll, such as cantaxanthin ( ⁇ , ⁇ -carotene-4,4'- dione) and/or astaxanthin.
- cantaxanthin ⁇ , ⁇ -carotene-4,4'- dione
- the naturally occurring synthesis of carotenoids involves a number of enzymes, namely 1-D-deoxyxylulose 5-phosphate synthase, isopentenyl pyrophosphate:dimethylallyl pyrophosphate isomerase, geranylgeranyl pyrophosphate synthase, phytoene synthase, phytoene desaturase, zeta-carotene desaturase, lycopene beta- cyclase, ⁇ -carotene hydroxylase, and ⁇ -carotene C-4-oxygenase.
- enzymes namely 1-D-deoxyxylulose 5-phosphate synthase, isopentenyl pyrophosphate:dimethylallyl pyrophosphate isomerase, geranylgeranyl pyrophosphate synthase, phytoene synthase, phytoene desaturase, zeta-carotene desaturase, lycopene beta-
- Genes coding for peptides having these enzymatic activities may be inserted into the DNA construct of the invention, one or several per construct, to promote high-level production in the transgenic oilseed plant. In case only one enzyme coding gene is inserted per plant, two or more plants may be sexually interbred to produce plants containing all the desired enzyme activities.
- the present invention is directed to a DNA construct comprising in the 5' to 3' direction of transcription operably linked a promoter region directing transcription to the seed of an oilseed plant, a nucleotide sequence coding for at least one peptide with enzyme activity necessary for keto group containing xanthophyll production and esterification in an oilseed plant and a transcriptional termination region.
- the DNA construct additionally comprises between the promoter region and the nucleotide sequence coding for at least one peptide with enzyme activity a nucleotide sequence coding for a transit peptide directing the translated fusion polypeptide to the chloroplast of the oilseed plant.
- the DNA construct is preferably such that the promoter is a napin promoter, the peptide with enzyme activity necessary for keto group containing xanthophyll production is selected from the group consisting of peptides with 1-D-deoxyxylulose 5-phosphate synthase, isopentenyl pyrophosphate:dimethylallyl pyrophosphate isomerase, geranylgeranyl pyrophosphate synthase, phytoene synthase, phytoene desaturase, zeta-carotene desaturase, lycopene beta-cyclase, ⁇ -carotene hydroxylase, and ⁇ -carotene C-4-oxygenase activity.
- a nucleotide sequence coding for a peptide with acyl transferase activity may be included in the group.
- the nucleotide sequence coding for a peptide with enzyme activity is a nucleotide sequence coding for a N-terminally truncated ⁇ -carotene C-4-oxygenase gene from the alga Haematococcus pluvialis.
- the present invention is also directed to a transgenic oilseed plant cell comprising the DNA construct of the invention, and preferably the oilseed plant is selected from the group consisting of rape, sunflower, soybean and mustard.
- the invention is additionally directed to transgenic oilseed plant-produced xanthophyll, e.g. canthaxanthin and astaxanthin.
- a preferred aspect of the invention is directed to transgenic oilseed plant- produced astaxanthin esters.
- Fig.l illustrates the nucleotide sequence of the DNA construct comprising the napin promoter, the chloroplast localization signal, the N-terminally truncated ⁇ -carotene C-4-oxygenase gene and the termination sequence, and the deduced amino acid sequences of the transit peptide and the ⁇ -carotene C-4-oxygenase.
- the invention is illustrated by production of astaxanthin in the seed of oilseed rape.
- the astaxanthin produced in the seed of the transgenic plant is extracted as part of the extracted oil.
- transgenic plants are produced having a chimeric DNA construct that is genetically inherited and is able to produce astaxanthin.
- the nucleotide sequence of the chimeric DNA construct consist of four parts of different genetic origin namely: (1) a promoter, (2) a localization signal, (3) a ⁇ -carotene C-4- oxygenase coding region and (4) a termination sequence.
- the napin promoter directs transcription to the seed of oilseed rape (Stalberg et al 1996). This promoter was coupled to a localization signal similar but not identical to a transit peptide (TP) of Rbcsla (Krebbers, 1988) that directs the translated product of a fused gene to the chloroplast.
- TP transit peptide
- the promoter and the TP sequence were ligated to a part of the coding sequence of a ketolase gene BCK (Kajiwara et al. 1995). This enzyme oxygenates ⁇ -carotene to canthaxanthin, (Fraser et al. 1997).
- the chimeric DNA construct was then coupled to a suitable termination sequence, e.g. that of the Agrobacterium tumefaciens nopaline synthase gene (the nos 3' end)(Bevan et al. 1983), as illustrated in Fig.l. Cellular storage of Astaxantin
- an effective esterification of astaxanthin to fatty acids enables storage of the esterified molecules in triacylglycerol containing oleosomes.
- an acyl transferase can be claimed to be of fundamental importance for the process, as is proteins that can mediate transport of different forms of astaxanthin from the chloroplast to the vesicles.
- Napin promoter (GeneBank ACCESSION No. J02798) This promoter sequence, a 1145 base pair fragment including the 5' leader sequence has a unique Hindlll site at the 5' end. The 3' end was synthesized with an additionally 6 nucleotide BamHI site.
- BCK ⁇ -carotene C-4 oxygenase
- Genebank ACCESSION No. D45881 The BCK fragment was amplified by PCR including a 5' Xbal site and was ligated to the TP already described.
- the 5' primer (BCK1) used for PCR is homologous to the BCK sequence from nucleotide 264 and the 3' oligonucleotide (Ax40) ends with a stop codon and was synthesized with a Sad restriction site for cloning.
- the synthesized fragment was fused to the TP as shown in Fig 1.
- Sad 3 primer AX40 5 'CACCGAGCTCCATGACACTCTTGTGCAGA 3 ' Description of SEQ ID NO:l and SEQ ID NO:2
- the SEQ ID NO:l is a nucleotide sequence composed of the following features: Nucleotide No.
- the SEQ ID NO: 2 is a deduced amino acid sequence of the fusion protein of the transit peptide and the peptide with ⁇ -carotene C-4-oxygenase activity.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Nutrition Science (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Medicinal Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Enzymes And Modification Thereof (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
A DNA construct comprising in the 5' to 3' direction of transcription operably linked a promoter region directing transcription to the seed of an oilseed plant, a nucleotide sequence coding for at least one peptide with enzyme activity necessary for keto group containing xanthophyll production and esterification in an oilseed plant and a transcriptional termination region is disclosed. The DNA construct may additionally comprise a nucleotide sequence coding for a transit peptide directing the translated fusion polypeptide to the chloroplast of the oilseed plant. The peptide with enzyme activity is preferably a peptide with β-carotene C-4-oxygenase activity, e.g. from the alga <aematococcus pluvialis. Comprised by the invention are also a transgenic oilseed plant cell, e.g. of rape, sunflower, soybean or mustard origin, and a transgenic oilseed plant-produced xanthophyll, such as canthaxanthin or astaxanthin, and also astaxanthin esters.
Description
DNA construct and its use.
The present invention relates to a new DNA construct for transformation into oilseed plants. The DNA construct comprises nucleotide sequences encoding peptides with enzyme activities necessary for the high-level production and esterification of keto group-containing xanthophylls in oilseed plants.
Background of the invention Carotenoids are produced de novo by plants, fungi, algae and some bacteria. A number of biosynthetic steps are needed for the biological production of the carotenoids. There are two chemically different groups of carotenoids, namely carotenes containing only carbon and hydrogen molecules and xanthophylls containing oxygen in the molecule in addition to carbon and hydrogen.
The xanthophylls, and particularly astaxanthin (3,3'-dihydroxy-β-β-carotene-4,4'- dione), are often colored pigments and are used as such or as anti-oxidants. Carotenes are biological precursors for the production of the oxygen-containing xanthophylls. There are two types of enzymes responsible for the introduction of hydroxy groups and keto groups into the carotenes, namely hydroxylases and ketolases, respectively.
The keto group-containing xanthophyll astaxanthin, which has keto and hydroxy groups, is biosynthetically produced from beta-carotene. Large-scale production of xanthophylles from natural sources is at present performed by AstaCarotene AB, Gustavsberg, Sweden, by cultivation of the alga Haematococcus pluvialis for the production of astaxanthin in esterified form.
It would be desirable to be able to produce keto group-containing xanthophylls particularly astaxanthin, in oilseed plants. Oilseed plants have naturally β-carotene hydroxylases but lack β-carotene C-4-oxygenase enzymes or ketolases.
Description of the invention The present invention provides DNA constructs enabling and promoting production of keto group containing xanthophylls, especially astaxanthin, in oilseed plants, such as rape, sunflower, soybean and mustard. The DNA construct is transformed into the oilseed plant cell for expression of a protein or fused protein which has an enzyme activity enabling keto group insertion into a carotene or hydroxy carotene for the biosynthetic production of a keto group containing xanthophyll, such as cantaxanthin (β,β-carotene-4,4'- dione) and/or astaxanthin. Use is thus made of the biosynthetic pathway of the oilseed plant to
produce carotenoids. The naturally occurring synthesis of carotenoids involves a number of enzymes, namely 1-D-deoxyxylulose 5-phosphate synthase, isopentenyl pyrophosphate:dimethylallyl pyrophosphate isomerase, geranylgeranyl pyrophosphate synthase, phytoene synthase, phytoene desaturase, zeta-carotene desaturase, lycopene beta- cyclase, β-carotene hydroxylase, and β-carotene C-4-oxygenase. Genes coding for peptides having these enzymatic activities may be inserted into the DNA construct of the invention, one or several per construct, to promote high-level production in the transgenic oilseed plant. In case only one enzyme coding gene is inserted per plant, two or more plants may be sexually interbred to produce plants containing all the desired enzyme activities. Thus, the present invention is directed to a DNA construct comprising in the 5' to 3' direction of transcription operably linked a promoter region directing transcription to the seed of an oilseed plant, a nucleotide sequence coding for at least one peptide with enzyme activity necessary for keto group containing xanthophyll production and esterification in an oilseed plant and a transcriptional termination region. In a preferred embodiment of the invention the DNA construct additionally comprises between the promoter region and the nucleotide sequence coding for at least one peptide with enzyme activity a nucleotide sequence coding for a transit peptide directing the translated fusion polypeptide to the chloroplast of the oilseed plant.
The DNA construct is preferably such that the promoter is a napin promoter, the peptide with enzyme activity necessary for keto group containing xanthophyll production is selected from the group consisting of peptides with 1-D-deoxyxylulose 5-phosphate synthase, isopentenyl pyrophosphate:dimethylallyl pyrophosphate isomerase, geranylgeranyl pyrophosphate synthase, phytoene synthase, phytoene desaturase, zeta-carotene desaturase, lycopene beta-cyclase, β-carotene hydroxylase, and β-carotene C-4-oxygenase activity. To promote esterification of astaxanthin a nucleotide sequence coding for a peptide with acyl transferase activity may be included in the group.
In a preferred embodiment of the DNA construct according to the invention the nucleotide sequence coding for a peptide with enzyme activity is a nucleotide sequence coding for a N-terminally truncated β-carotene C-4-oxygenase gene from the alga Haematococcus pluvialis.
An example of the DNA construct of the invention is presented in the sequence listing as SEQ ID NO:l and in Fig.l.
The present invention is also directed to a transgenic oilseed plant cell comprising the DNA construct of the invention, and preferably the oilseed plant is selected from the group consisting of rape, sunflower, soybean and mustard.
The invention is additionally directed to transgenic oilseed plant-produced xanthophyll, e.g. canthaxanthin and astaxanthin.
A preferred aspect of the invention is directed to transgenic oilseed plant- produced astaxanthin esters.
The present invention will now be illustrated with reference to the DNA construct disclosed in the sequence listing and in Fig.l, and the following description of embodiments. However, the invention is not limited to these exemplifications.
Short description of the drawings Fig.l illustrates the nucleotide sequence of the DNA construct comprising the napin promoter, the chloroplast localization signal, the N-terminally truncated β-carotene C-4-oxygenase gene and the termination sequence, and the deduced amino acid sequences of the transit peptide and the β-carotene C-4-oxygenase.
Description of embodiments The invention is illustrated by production of astaxanthin in the seed of oilseed rape. The astaxanthin produced in the seed of the transgenic plant is extracted as part of the extracted oil. By use of conventionally used protocols for Agrobacterium tumefaciens mediated transformation such as described by (Hoekema et al.1983, An et al. 1986, Fry et al. 1987, DeBlock et al. 1988, Radke et al.1988, or Moloney et al. 1989) transgenic plants are produced having a chimeric DNA construct that is genetically inherited and is able to produce astaxanthin. The nucleotide sequence of the chimeric DNA construct consist of four parts of different genetic origin namely: (1) a promoter, (2) a localization signal, (3) a β-carotene C-4- oxygenase coding region and (4) a termination sequence.
The napin promoter directs transcription to the seed of oilseed rape (Stalberg et al 1996). This promoter was coupled to a localization signal similar but not identical to a transit peptide (TP) of Rbcsla (Krebbers, 1988) that directs the translated product of a fused gene to the chloroplast. The promoter and the TP sequence were ligated to a part of the coding sequence of a ketolase gene BCK (Kajiwara et al. 1995). This enzyme oxygenates β-carotene to canthaxanthin, (Fraser et al. 1997). The chimeric DNA construct was then coupled to a suitable termination sequence, e.g. that of the Agrobacterium tumefaciens nopaline synthase gene (the nos 3' end)(Bevan et al. 1983), as illustrated in Fig.l.
Cellular storage of Astaxantin
The storage of large amounts of free astaxanthin in plants will be difficult due to toxic effects of the molecule as it intercalates in the plant membranes. An effective esterification of astaxanthin to fatty acids enables storage of the esterified molecules in triacylglycerol containing oleosomes. Thus, an acyl transferase can be claimed to be of fundamental importance for the process, as is proteins that can mediate transport of different forms of astaxanthin from the chloroplast to the vesicles.
Sequences and oligonucleotides used in the construction of the DNA construct
1. Napin promoter (GeneBank ACCESSION No. J02798) This promoter sequence, a 1145 base pair fragment including the 5' leader sequence has a unique Hindlll site at the 5' end. The 3' end was synthesized with an additionally 6 nucleotide BamHI site.
2. Transit peptide similar to RBCSla (GeneBank ACCESSION No. XI 3611, X14565)
The transit peptide (TP) was amplified by PCR from -28 to the end of the transit cleavage aa=54/55 site of the Rbcsla gene. The 5' end was synthesized with a BamHI site and similarly the 3' sequence was synthesized with a Xbal site. The two following oligonucleotides were used for the PCR amplification.
BamHI 5 ' primer: TP 1 5 'AGAC GGATCC TCAGTC AC AC AAAGAGT A 3 '
Sad Xbal
3 ' primer: TP2 5 'GTTC GAGCTC TCTAG A CATGCAGTTAACGC 3 '
3. BCK (β-carotene C-4 oxygenase) (Genebank ACCESSION No. D45881) The BCK fragment was amplified by PCR including a 5' Xbal site and was ligated to the TP already described. The 5' primer (BCK1) used for PCR, is homologous to the BCK sequence from nucleotide 264 and the 3' oligonucleotide (Ax40) ends with a stop codon and was synthesized with a Sad restriction site for cloning. The synthesized fragment was fused to the TP as shown in Fig 1. Oligonucleotides used for PCR:
Xbal 5 ' primer: BCK1 5 'ACAG TCTAGA ATGCCATCCGAGTCGTCA 3 '
Sad 3 primer: AX40 5 'CACCGAGCTCCATGACACTCTTGTGCAGA 3 '
Description of SEQ ID NO:l and SEQ ID NO:2
The sequences shown i Fig.1 are the same as the two sequences which are shown in the sequence listing.
The SEQ ID NO:l is a nucleotide sequence composed of the following features: Nucleotide No.
Cloning site Hindlll 1-6
Napin Promoter 1-1145
Cloning site BamHI 1146-1151
Transit peptide leader 1152-1178 Transit peptide coding 1179- 1347
Cloning site Xbal 1348-1353 β-carotene C-4-oxygenase 1354-2217 β-carotene C-4-oxygense 3' untranslated 2218-2266
Cloning site Sad 2267-2272 Nopaline synthetase termination 2273-2536
Cloning site EcoRI 2538-2543
The SEQ ID NO: 2 is a deduced amino acid sequence of the fusion protein of the transit peptide and the peptide with β-carotene C-4-oxygenase activity.
References
An G, Watson BD, Chiang CC (1986), Transformation of tobacco, tomato, potato and Arabidopsis-thaliana using a binary vector system. Plant Physiology 81 (1) 301-305.
Bevan M, Barnes WM and Chilton MD (1983). Structure and transcription of the nopaline synthase gene region of T-DNA. Nucleic Acids Res. 11 (2), 369-385 .
DeBlock M, DeBrouwer D, Tenning P (1989). Transformation of Brassica napus and Brassica oleracea using Agrobacterium tumefaciens and the expression of the BAR and NEO genes in transgenic plants Plant Physiology 91:2, 694-701.
Fraser PD, Miura Y, Misawa N, (1997). In vitro characterization of astaxanthin biosynthetic enzymes. J Biol Chem. Mar 7;272(10):6128-35.
Fry J, Barnason A, and Horsch RB, (1987). Transformation of Brassica napus with Agrobacteriium tumefaciens based vectors. Plant Cell Reports 6:321-325.
Hoekema A, Hirsch PR, Hooykas PJJ Schilperoort, (1983). A binary vector strategy based on separation of vir and T-region of the Agrobacterium tumefaciens Ti-plasmid. Nature vol 303, 179-180.
Josefsson LG, Lenman M, Ericson ML and Rask L, (1987). Structure of a gene encoding the 1.7 S storage protein, napin, from Brassica napus. J. Biol. Chem. 262 (25), 12196-12201.
Kajiwara S, KakizonoT, Saito T, Kondo K, OhtaniT, Nishio N, Nagai S and Misawa N. (1995). Isolation and functional identification of a novel cDNA for astaxanthin biosynthesis from Haematococcus pluvialis, and astaxanthin synthesis in Escherichia coli Plant Mol. Biol. 29 (2), 343-352.
Krebbers E, Seurinck J, Herdies L, Cashmore AR and Timko MP, (1988). Four genes in two diverged subfamilies encode the rubulose-1, 5-bisphosphate carboxylase small subunit polypeptides of Arabidopsis thaliana Plant Mol. Biol. 11, 745-759.
Moloney M, Walker JM and Sharma KK, (1989). High efficiency transformation of Brassica napus using Agrobacterium vectors. Plant Cell Reports 8:238-242.
Radke SE, Andrews BM, Moloney MM, Crouch ML, Kridl JC, Knauf VC (1988), Transformation of Brassica napus using Agrobacterium tumefaciens - Developmentally regulated Expression of a reintroduced napin gene. TAG, 75: (5) 685-694 .
Pua E-C, Mehra-Palta A, Nagy F and Chua N-H, (1987). Transgenic plants of Brassica napus. Biotechnology vol 5, 815-817.
Stalberg K, Ellerstόm M, Ezcurra I, Ablov S, Rask L (1996). Disruption of an overlapping E- box/ABRE motif abolished high transcription of the nap A storage-protein promoter in transgenic Brassica napus seeds. Planta 199(4):515-9.
Claims
1. A DNA construct comprising in the 5' to 3' direction of transcription operably linked a promoter region directing transcription to the seed of an oilseed plant, a nucleotide sequence coding for at least one peptide with enzyme activity necessary for keto group containing xanthophyll production and esterification in an oilseed plant and a transcriptional termination region.
2. The DNA construct according to claim 1, which between the promoter region and the nucleotide sequence coding for at least one peptide with enzyme activity additionally comprises a nucleotide sequence coding for a transit peptide directing the translated fusion polypeptide to the chloroplast of the oilseed plant.
3. The DNA construct according to claim 1 or 2, wherein the promoter is a napin promoter, the peptide with enzyme activity necessary for keto group containing xanthophyll production and esterification is selected from the group consisting of peptides with, 1-D- deoxyxylulose 5-phosphate synthase, isopentenyl pyrophosphate:dimethylallyl pyrophosphate isomerase, geranylgeranyl pyrophosphate synthase, phytoene synthase, phytoene desaturase, zeta-carotene desaturase, lycopene beta-cyclase, β-carotene hydroxylase, β-carotene C-4- oxygenase, and acyl transferase activity.
4. The DNA construct according to any one of claims 1 - 3, wherein the nucleotide sequence coding for a peptide with enzyme activity is a nucleotide sequence coding for a N-terminally truncated β-carotene C-4-oxygenase gene from the alga Haematococcus pluvialis.
5. The DNA construct according to claim 4, wherein the nucleotide sequence is SEQ ID NO: 1.
6. Transgenic oilseed plant cell comprising the DNA construct of any one of claims 1-5 .
7. Transgenic oilseed plant cell according to claim 6, wherein the oilseed plant is selected from the group consisting of rape, sunflower, soybean and mustard.
8. Transgenic oilseed plant-produced xanthophyll.
9. Transgenic oilseed plant-produced xanthophyll according to claim 8, wherein the xanthophyll is canthaxanthin
10. Transgenic oilseed plant-produced xanthophyll according to claim 8, wherein the xanthophyll is astaxanthin.
11. Transgenic oilseed plant-produced xanthophyll according to claim 8, wherein the xanthophyll is astaxanthin esters.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9903336A SE9903336D0 (en) | 1999-09-17 | 1999-09-17 | DNA construct and its use |
SE9903336 | 1999-09-17 | ||
PCT/SE2000/001767 WO2001020011A1 (en) | 1999-09-17 | 2000-09-13 | Dna construct and its use |
Publications (1)
Publication Number | Publication Date |
---|---|
EP1212444A1 true EP1212444A1 (en) | 2002-06-12 |
Family
ID=20417035
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP00966616A Withdrawn EP1212444A1 (en) | 1999-09-17 | 2000-09-13 | Dna construct and its use |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1212444A1 (en) |
JP (1) | JP2003509057A (en) |
AU (1) | AU7693600A (en) |
CA (1) | CA2382444A1 (en) |
NO (1) | NO20021305L (en) |
SE (1) | SE9903336D0 (en) |
WO (1) | WO2001020011A1 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7214520B2 (en) | 2000-07-18 | 2007-05-08 | National Research Council Of Canada | Cloning, sequencing and expression of a comamonas cyclopentanone 1,2-monooxygenase-encoding gene in Escherichia coli |
EP1542945A2 (en) | 2002-08-20 | 2005-06-22 | Sungene GmbH & Co. KGaA | Method for the production of zeaxanthin and/or the biosynthetic intermediates and/or subsequent products thereof |
DE10321963A1 (en) * | 2003-05-15 | 2004-12-02 | Icon Genetics Ag | Process for the production of a plastid-directed protein in plant cells |
UA94038C2 (en) | 2005-03-18 | 2011-04-11 | Майкробиа, Инк. | Production of carotenoids in oleaginous yeast and fungi |
US20070293568A1 (en) | 2006-06-16 | 2007-12-20 | Yamaha Hatsudoki Kabushiki Kaisha | Neurocyte Protective Agent |
WO2008042338A2 (en) | 2006-09-28 | 2008-04-10 | Microbia, Inc. | Production of carotenoids in oleaginous yeast and fungi |
CA2767724A1 (en) | 2009-07-23 | 2011-01-27 | Chromatin, Inc. | Sorghum centromere sequences and minichromosomes |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5618988A (en) * | 1990-03-02 | 1997-04-08 | Amoco Corporation | Enhanced carotenoid accumulation in storage organs of genetically engineered plants |
US5916791A (en) * | 1995-11-24 | 1999-06-29 | Hirschberg; Joseph | Polynucleotide molecule from Haematococcus pluvialis encoding a polypeptide having a β--C--4--oxygenase activity for biotechnological production of (3S,3S)astaxanthin |
US6429356B1 (en) * | 1996-08-09 | 2002-08-06 | Calgene Llc | Methods for producing carotenoid compounds, and specialty oils in plant seeds |
BR9713462A (en) * | 1996-08-09 | 2000-03-28 | Calgene Inc | Methods for producing carotenoid compounds and special oils in plant seeds. |
SE522246C2 (en) * | 1997-02-27 | 2004-01-27 | Astacarotene Ab | Oral preparation for prophylactic and therapeutic treatment of Helicobacter Sp. infection |
SE511237C2 (en) * | 1997-12-16 | 1999-08-30 | Astacarotene Ab | Use of at least one type of xanthophyll for the preparation of a human or veterinary drug for the prophylactic treatment of mastitis in mammalian mothers |
-
1999
- 1999-09-17 SE SE9903336A patent/SE9903336D0/en unknown
-
2000
- 2000-09-13 WO PCT/SE2000/001767 patent/WO2001020011A1/en not_active Application Discontinuation
- 2000-09-13 EP EP00966616A patent/EP1212444A1/en not_active Withdrawn
- 2000-09-13 AU AU76936/00A patent/AU7693600A/en not_active Abandoned
- 2000-09-13 JP JP2001523782A patent/JP2003509057A/en active Pending
- 2000-09-13 CA CA002382444A patent/CA2382444A1/en not_active Abandoned
-
2002
- 2002-03-15 NO NO20021305A patent/NO20021305L/en not_active Application Discontinuation
Non-Patent Citations (1)
Title |
---|
See references of WO0120011A1 * |
Also Published As
Publication number | Publication date |
---|---|
JP2003509057A (en) | 2003-03-11 |
NO20021305D0 (en) | 2002-03-15 |
AU7693600A (en) | 2001-04-17 |
SE9903336D0 (en) | 1999-09-17 |
CA2382444A1 (en) | 2001-03-22 |
WO2001020011A1 (en) | 2001-03-22 |
NO20021305L (en) | 2002-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6787683B1 (en) | Phytyl/prenyltransferase nucleic acids, polypeptides and uses thereof | |
US5618988A (en) | Enhanced carotenoid accumulation in storage organs of genetically engineered plants | |
JP4515904B2 (en) | Fatty acid desaturase from fungi | |
EP1709179B1 (en) | Transgenic plants with reduced level of saturated fatty acid and methods for making them | |
EP0746615B1 (en) | Dna constructs, cells and plants derived therefrom | |
JP2004514401A (en) | Transgenic plants containing tocopherol methyltransferase | |
CA2491234A1 (en) | Use of a gene for increasing the oil content in plants | |
US8557585B2 (en) | Fusion polynucleotide for biosynthesis of beta-carotene using bicistronic gene expression and method for producing beta-carotene using the same | |
US20150322444A1 (en) | Enhanced accumulation of carotenoids in plants | |
WO2001020011A1 (en) | Dna construct and its use | |
KR100905219B1 (en) | Fusion polynucleotide for biosynthesis of beta-carotene comprising self-cleavage 2A sequence and transformed cell using the same | |
CA2423502A1 (en) | Triacylglycerol lipases from arabidopsis thaliana |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20020226 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI |
|
17Q | First examination report despatched |
Effective date: 20030627 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN |
|
18W | Application withdrawn |
Effective date: 20050504 |